One-year antibody persistence and safety of a 4-dose schedule of MenACWY-CRM in healthy infants from South Korea

Purpose Results from a post-marketing study to generate evidence on 1-year antibody persistence and safety following vaccination of infants from South Korea with the quadrivalent meningococcal conjugate vaccine MenACWY-CRM.